Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)

This study is building a Community Advisory Board (CAB) to help make clinical trials more inclusive and representative of diverse populations. Advisory board members will review trial designs and provide feedback to researchers. **You may be eligible if...** - You are 18 or older and speak English - You are a patient or community member willing to provide feedback on clinical research - Dana-Farber Cancer Institute (DFCI) patients who have been in remission from a blood cancer for over 1 year are preferred **You may NOT be eligible if...** - You are under 18 years old - You are a prisoner - You are unable to give oral consent - You are unwilling to maintain confidentiality of clinical trial materials reviewed Talk to your doctor to see if this trial is right for you.